Novel Alpha-Helix Mimetics as Anti-Cancer Leads

Projektinformationen

NHELMIMACANL

ID Finanzhilfevereinbarung: 327114

Projekt abgeschlossen

Startdatum 6 Januar 2014

Enddatum 5 Januar 2016

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 231 283,20

EU-Beitrag € 231 283,20

Koordiniert durch

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom